A meta-analysis of randomized trials of maintenance bacillus Calmette-Guerin instillation efficacy against recurrence of T1G3 bladder tumor

Frontiers of Medicine in China

Volumn 2, Issue 3, 2008, Pages 259-263

  Pan, Jiangang ^a   Zhou, Xing ^a   Han, Ruifa ^b   Chen, Zhiguang ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Odds ratio; Recurrence; Tumor1 grade 3; Urinary bladder neoplasms

Indexed keywords

EID: 48749089914     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-008-0049-3     Document Type: Article

References (24)

1. Pham H T, Soloway M S. High-risk superficial bladder cancer: intravesical therapy for T1, G3 transitional cell carcinoma of the urinary. Semin Urol Oncol, 1997, 15(3): 147-153
2. Jakse G, Loidl W, Seeber G, Hofstädter F. Stage T1, Grade 3 transitional cell carcinoma of the bladder: An unfavorable tumor? J Urol, 1987, 137(1): 39-43
3. Amling C L, Thrasher J B, Frazier H A, Dodge R K, Robertson J E, Paulson D F. Radical cystectomy for stage Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol. 1994, 151(1): 31-35
4. Kakizoe T, Tobisu K, Mizutani T, Tsutsumi M, Tanaka Y, Sakamoto M. An analysis by step sectioning of early invasive bladder cancer with special reference to G3, pT1 disease. Jpn J Cancer Res, 1992, 83(12): 1354-1358
5. Coolson M S, Sarosdy M F. Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy. J Urol, 1992, 148(3): 797-801
6. Stockle M, Alken P, Engelmann U, Jacobi G H, Riedmiller H, Hohenfellner R. Radical cystectomy-often too late? Eur Urol, 1987, 13(6): 361-367
7. Eure G R, Cundiff M R, Schellhammer P F. Bacillus Calmette-Guerin therapy for high risk stage T1superficial bladder cancer. J Urol, 1992, 147(2): 376-379
8. Richard J, Adrian P M, P R Donald L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials. J Urol, 2002, 168(5): 1964-1970
9. Yet P, Debruyne F M, van der Meijden A P. Bacillus Calmette-Guerin bladder cancer. Eur Urol, 1995, 27(1): 89-95
10. Shahin O, Scholz M, Thalmann G, Mazzucchelli L, Studer U E. Can radicaila cystectomy be prevented or deffered by BCG instillation therapy in patients with primary T1G3 cancer? A retrospective analysis of 153 patients. Eur Urol, 2001, 39(suppl 5): 117
11. Hara I, Miyake H, Takechi Y, Eto H, Gotoh A, Fujisawa M, Okada H, Arakawa S, Kamidono S. Kobe Urogenital Tumor Study Group. Clinical outcome of conservative therapy for stage T1, grade 3 transitional cell carcinoma of the bladder. Int J Urol, 2003, 10(1): 19-24
12. Brake M, Loertzer H, Horsch R, Keller H. Long-term results of intravesical bacillus Calmette-Guerin therapy for stage T1 superficial bladder cancer. Urology, 2000, 55(5): 673-678
13. Kolodziej A, Dembowski J, Zdrojowy R, Wozniak P, Lorenz J. Treatment of high-risk superficial bladder cancer with maintenance bacille Calmette-Guerin therapy: Preliminary results. BJU Int, 2002, 89(6): 620-622
14. Brake M, Loertzer H, Horsch R, Keller H. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. J Urol, 2000, 163(6): 1697-1701
15. Kulkarni J N, Gupta R. Recurrence and progression in stage T1G3 bladder tumour with intravesical bacille Calmette-Guerin (Danish 1331 strain). BJU Int, 2002, 90(6): 554-557
16. Peyromaure M, Zerbib M. T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival. BJU Int, 2004, 93(1): 60-63
17. Palou J, Laguna P, Millan-Rodriguez F, Hall R R, Hall R R, Salvador-Bayarri J, Vicente-Rodríguez J. Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors. J Urol, 2001, 165(5): 1488-1491
18. Martínez-Piñeiro J A, Martínez-Piñeiro L, Solsona E, Rodríguez R H, Gómez J M, Martín M G, Molina J R, Collado A G, Flores N, Isorna S, Pertusa C, Rabadán M, Astobieta A, Camacho J E, Arribas S, Madero R. Club Urológico Español de Tratamiento Oncológico (CUETO). Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. J Urol, 2005, 174(4): 1242-1247
19. Cheng C W, Chan S F, Chan L W, Chan C K, Ng C F, Cheung H Y, Chan S Y, Wong W S, Lai F M, To K F, Li M L. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer. Int J Urol, 2005, 12(5): 449-455
20. Patard J J, Rodriguez A, Leray E. Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours. Eur Urol, 2002, 41(6): 635-641
21. Patard J, Moudouni S, Saint F, Rioux-Leclercq N, Manunta A, Guy L, Ballanger P, Lanson Y, Hajri M, Irani J, Guillé F, Beurton D, Lobel B, Bernard Lobel and The members of the Groupe Necker. Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years. Urology. 2001, 58(4): 551-556
22. Osama Shahin, George N, Thaimann, Cyrill Rentsch, Mazzucchelli L, Studer U E. A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: Recurrence, progression and survival. J Urol, 2003, 169(1): 96-100
23. A Bohle, D Jcham, P R Bock. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials. Int Braz J Urol, 2002, 28(6): 585-586
24. Morales A, Eidinger D, Bruce A W. Intracavitary BCG in treatment of superficial bladder tumor. J Urol, 1976, 116(2): 180-183